
Aktis Oncology, Inc.
USD24.63
+0.67 (+2.80%)
CEO
Matthew Roden
IPO Date
2026-01-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$23.76
Prev. Close
$23.96
Day Low
$23.76
Day High
$25.22
52W Low
$14.72
52W High
$34.19
Market Cap
$1.32B
Volume
0.24M
| 4 Jan 2024 |
| Piper Sandler |
| Overweight |
| Neutral |
| downgrade |
| 7 Sept 2023 | Oppenheimer | Outperform | Outperform | maintain |
| 7 Sept 2023 | B. Riley Securities | Buy | Neutral | downgrade |
| 9 May 2023 | Roth MKM | Buy | Buy | maintain |
| 9 May 2023 | Oppenheimer | Outperform | Outperform | maintain |
| 15 Nov 2022 | Oppenheimer | Outperform | Outperform | maintain |
| 13 Sept 2022 | Piper Sandler | Overweight | Overweight | maintain |